Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 5:24 PM
Ignite Modification Date: 2025-12-25 @ 2:59 PM
NCT ID: NCT04711850
Description: Only AEs related to trial procedure or related to IMP administered in feeder trial were to be collected.
Frequency Threshold: 0
Time Frame: From inclusion in the study until end of study (Year 3).
Study: NCT04711850
Study Brief: An Long-term Follow-up Trial of Kidney Tx Patients Treated With Imlifidase or PE After an AMR
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Imlifidase Treatment in Feeder Study 16-HMedIdeS-12 No treatment is given in this long-term follow-up study. In the feeder study (16-HMedIdeS-12) the patients in this group were treated with imlifidase. Imlifidase: Immunoglobulin G degrading enzyme of Streptococcus pyogenes 0 None 0 11 0 11 View
Plasma Exchange (PE) Treatment in Feeder Study 16-HMedIdeS-12 No treatment is given in this long-term follow-up study. In the feeder study (16-HMedIdeS-12) the patients in this group were treated with PE. 0 None 0 7 0 7 View
Serious Events(If Any):
Other Events(If Any):